 | 624 | Name: | 2-(2-(3,4-DICHLOROPHENYL)-5-(ISOPROPYLAMINO)-6-OXOPYRIMIDIN-1(6H)-YL)-N-((S)-1-OXO-1-(THIAZOL-2-YL)-5-GUANIDINOPENTAN-2-YL)ACETAMIDE | Formula: | C24 H28 Cl2 N8 O3 S | SMILES: | O=C(c1nccs1)C(NC(=O)CN2C(=NC=C(NC(C)C)C2=O)c3ccc(Cl)c(Cl)c3)CCCNC(=[N@H])N | InChi: | InChI=1S/C24H28Cl2N8O3S/c1-13(2)32-18-11-31-21(14-5-6-15(25)16(26)10-14)34(23(18)37)12-19(35)33-17(4-3-7-30-24(27)28)20(36)22-29-8-9-38-22/h5-6,8-11,13,17,32H,3-4,7,12H2,1-2H3,(H,33,35)(H4,27,28,30)/t17-/m0/s1 | Definition date: | 2005-06-22 | Last modified: | 2024-09-27 | Identifier: | N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]-2-[2-(3,4-dichlorophenyl)-5-[(1-methylethyl)amino]-6-oxopyrimidin-1(6H)-yl]acetamide |
|
 | 62A | Name: | 2-(5-AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE | Formula: | C22 H26 N8 O3 S | SMILES: | O=C(c1nccs1)C(NC(=O)CN2C(=NC=C(N)C2=O)c3cccc(c3)C)CCCNC(=[N@H])N | InChi: | InChI=1S/C22H26N8O3S/c1-13-4-2-5-14(10-13)19-28-11-15(23)21(33)30(19)12-17(31)29-16(6-3-7-27-22(24)25)18(32)20-26-8-9-34-20/h2,4-5,8-11,16H,3,6-7,12,23H2,1H3,(H,29,31)(H4,24,25,27)/t16-/m0/s1 | Definition date: | 2005-06-03 | Last modified: | 2024-09-27 | Identifier: | 2-[5-amino-2-(3-methylphenyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide |
|
 | 632 | Name: | 2-(5-BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE | Formula: | C23 H28 N8 O3 S2 | SMILES: | O=C(c1nccs1)C(NC(=O)CN3C(SC)=NC=C(NCc2ccccc2)C3=O)CCCNC(=[N@H])N | InChi: | InChI=1S/C23H28N8O3S2/c1-35-23-29-13-17(28-12-15-6-3-2-4-7-15)21(34)31(23)14-18(32)30-16(8-5-9-27-22(24)25)19(33)20-26-10-11-36-20/h2-4,6-7,10-11,13,16,28H,5,8-9,12,14H2,1H3,(H,30,32)(H4,24,25,27)/t16-/m0/s1 | Definition date: | 2005-06-03 | Last modified: | 2024-09-27 | Identifier: | 2-[5-(benzylamino)-2-(methylsulfanyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide |
|
 | JJJ | Name: | S-(pyridin-3-ylcarbonyl)-L-cysteine | Formula: | C9 H10 N2 O3 S | SMILES: | O=C(O)C(N)CSC(=O)c1cccnc1 | InChi: | InChI=1S/C9H10N2O3S/c10-7(8(12)13)5-15-9(14)6-2-1-3-11-4-6/h1-4,7H,5,10H2,(H,12,13)/t7-/m0/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | S-(pyridin-3-ylcarbonyl)-L-cysteine |
|
 | JJK | Name: | S-[(S)-hydroxy(pyridin-3-yl)methyl]-L-cysteine | Formula: | C9 H12 N2 O3 S | SMILES: | O=C(O)C(N)CSC(O)c1cccnc1 | InChi: | InChI=1S/C9H12N2O3S/c10-7(8(12)13)5-15-9(14)6-2-1-3-11-4-6/h1-4,7,9,14H,5,10H2,(H,12,13)/t7-,9-/m0/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | S-[(S)-hydroxy(pyridin-3-yl)methyl]-L-cysteine |
|
 | JJL | Name: | S-[(S)-hydroxy(5-methoxypyridin-3-yl)methyl]-L-cysteine | Formula: | C10 H14 N2 O4 S | SMILES: | O=C(O)C(N)CSC(O)c1cncc(OC)c1 | InChi: | InChI=1S/C10H14N2O4S/c1-16-7-2-6(3-12-4-7)10(15)17-5-8(11)9(13)14/h2-4,8,10,15H,5,11H2,1H3,(H,13,14)/t8-,10-/m0/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | S-[(S)-hydroxy(5-methoxypyridin-3-yl)methyl]-L-cysteine |
|
 | 682 | Name: | N~2~-(AMINOCARBONYL)-N~1~-{4-{[AMINO(IMINO)METHYL]AMINO}-1-[HYDROXY(1,3-THIAZOL-2-YL)METHYL]BUTYL}VALINAMIDE | Formula: | C15 H27 N7 O3 S | SMILES: | O=C(N)NC(C(=O)NC(C(O)c1nccs1)CCCNC(=[N@H])N)C(C)C | InChi: | InChI=1S/C15H27N7O3S/c1-8(2)10(22-15(18)25)12(24)21-9(4-3-5-20-14(16)17)11(23)13-19-6-7-26-13/h6-11,23H,3-5H2,1-2H3,(H,21,24)(H4,16,17,20)(H3,18,22,25)/t9-,10-,11-/m0/s1 | Definition date: | 2006-01-10 | Last modified: | 2024-09-27 | Identifier: | N-{(1S)-4-carbamimidamido-1-[(S)-hydroxy(1,3-thiazol-2-yl)methyl]butyl}-N~2~-carbamoyl-L-valinamide |
|
 | 339 | Name: | (S)-2-(3-((R)-1-(4-BROMOPHENYL)ETHYL)UREIDO)-N-((S)-1-((S)-5-GUANIDINO-1-OXO-1-(THIAZOL-2-YL)PENTAN-2-YLAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-5-UREIDOPENTANAMIDE | Formula: | C29 H45 Br N10 O5 S | SMILES: | O=C(c1nccs1)C(NC(=O)C(NC(=O)C(NC(=O)NC(c2ccc(Br)cc2)C)CCCNC(=O)N)C(C)C)CCCNC(N)N | InChi: | InChI=1S/C29H45BrN10O5S/c1-16(2)22(25(43)38-20(6-4-12-35-27(31)32)23(41)26-34-14-15-46-26)40-24(42)21(7-5-13-36-28(33)44)39-29(45)37-17(3)18-8-10-19(30)11-9-18/h8-11,14-17,20-22,27,35H,4-7,12-13,31-32H2,1-3H3,(H,38,43)(H,40,42)(H3,33,36,44)(H2,37,39,45)/t17-,20+,21+,22+/m1/s1 | Definition date: | 2005-05-25 | Last modified: | 2024-09-27 | Identifier: | 2-[N~2~-{[(1R)-1-(4-bromophenyl)ethyl]carbamoyl}-N~5~-carbamoyl-L-ornithyl-L-valyl-N~5~-(diaminomethyl)-L-ornithyl]-1,3-thiazole |
|
 | 3GC | Name: | GAMMA-GLUTAMYLCYSTEINE | Formula: | C8 H14 N2 O5 S | SMILES: | O=C(O)C(NC(=O)CCC(C(=O)O)N)CS | InChi: | InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/t4-,5-/m0/s1 | Definition date: | 2002-07-01 | Last modified: | 2024-09-27 | Identifier: | L-gamma-glutamyl-L-cysteine |
|
 | NCY | Name: | N-METHYLCYSTEINE | Formula: | C4 H9 N O2 S | SMILES: | O=C(O)C(NC)CS | InChi: | InChI=1S/C4H9NO2S/c1-5-3(2-8)4(6)7/h3,5,8H,2H2,1H3,(H,6,7)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-methyl-L-cysteine |
|
 | UJR | Name: | (2~{R})-2-azanyl-3-(5-iodanylpyrimidin-2-yl)sulfanyl-propanal | Formula: | C7 H8 I N3 O S | SMILES: | N[CH](CSc1ncc(I)cn1)C=O | InChi: | InChI=1S/C7H8IN3OS/c8-5-1-10-7(11-2-5)13-4-6(9)3-12/h1-3,6H,4,9H2/t6-/m1/s1 | Synonyms: | arylated cysteine | Definition date: | 2023-02-06 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | (2~{R})-2-azanyl-3-(5-iodanylpyrimidin-2-yl)sulfanyl-propanal |
|
 | J3D | Name: | N-carboxy-L-cysteine | Formula: | C4 H7 N O4 S | SMILES: | C(S)C(C(O)=O)NC(=O)O | InChi: | InChI=1S/C4H7NO4S/c6-3(7)2(1-10)5-4(8)9/h2,5,10H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1 | Definition date: | 2018-08-06 | Last modified: | 2024-09-27 | Release date: | 2019-08-07 | Identifier: | N-carboxy-L-cysteine |
|
 | UUR | Name: | 2-phenylsulfanylethyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate | Formula: | C22 H33 N3 O8 S2 | SMILES: | CC(C)CC(NC(=O)OCCSc1ccccc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C22H33N3O8S2/c1-14(2)12-17(25-22(29)33-10-11-34-16-6-4-3-5-7-16)20(27)24-18(21(28)35(30,31)32)13-15-8-9-23-19(15)26/h3-7,14-15,17-18,21,28H,8-13H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t15-,17-,18-,21-/m0/s1 | Definition date: | 2022-08-26 | Last modified: | 2024-09-27 | Release date: | 2022-09-07 | Identifier: | (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-[(N-{[2-(phenylsulfanyl)ethoxy]carbonyl}-L-leucyl)amino]propane-1-sulfonic acid |
|
 | V44 | Name: | S-[2,2-bis(1-methyl-1H-imidazol-2-yl)ethyl]-L-cysteine | Formula: | C13 H19 N5 O2 S | SMILES: | C(=O)(C(N)CSCC(c1nccn1C)c2n(ccn2)C)O | InChi: | InChI=1S/C13H19N5O2S/c1-17-5-3-15-11(17)9(12-16-4-6-18(12)2)7-21-8-10(14)13(19)20/h3-6,9-10H,7-8,14H2,1-2H3,(H,19,20)/t10-/m0/s1 | Definition date: | 2020-06-23 | Last modified: | 2024-09-27 | Release date: | 2021-06-30 | Identifier: | S-[2,2-bis(1-methyl-1H-imidazol-2-yl)ethyl]-L-cysteine |
|
 | 6KM | Name: | S-propanoyl-L-cysteine | Formula: | C6 H11 N O3 S | SMILES: | NC(CSC(CC)=O)C(=O)O | InChi: | InChI=1S/C6H11NO3S/c1-2-5(8)11-3-4(7)6(9)10/h4H,2-3,7H2,1H3,(H,9,10)/t4-/m0/s1 | Definition date: | 2016-04-22 | Last modified: | 2024-09-27 | Release date: | 2017-03-01 | Identifier: | S-propanoyl-L-cysteine |
|
 | 6M6 | Name: | S-[(2-phenylethyl)carbamothioyl]-L-cysteine | Formula: | C12 H16 N2 O2 S2 | SMILES: | S(C(NCCc1ccccc1)=S)CC(C(O)=O)N | InChi: | InChI=1S/C12H16N2O2S2/c13-10(11(15)16)8-18-12(17)14-7-6-9-4-2-1-3-5-9/h1-5,10H,6-8,13H2,(H,14,17)(H,15,16)/t10-/m0/s1 | Definition date: | 2016-05-05 | Last modified: | 2024-09-27 | Release date: | 2016-10-12 | Identifier: | S-[(2-phenylethyl)carbamothioyl]-L-cysteine |
|
 | LAS | Name: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine | Formula: | C15 H24 N2 O7 S | SMILES: | O=C1NC(C(=O)SCC(C(=O)O)NC(=O)C)(C(O)C1C)C(O)C(C)C | InChi: | InChI=1S/C15H24N2O7S/c1-6(2)10(19)15(11(20)7(3)12(21)17-15)14(24)25-5-9(13(22)23)16-8(4)18/h6-7,9-11,19-20H,5H2,1-4H3,(H,16,18)(H,17,21)(H,22,23)/t7-,9?,10+,11+,15-/m1/s1 | Synonyms: | LACTACYSTIN | Definition date: | 2008-07-10 | Last modified: | 2024-09-27 | Identifier: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine |
|
 | M0H | Name: | S-(HYDROXYMETHYL)-L-CYSTEINE | Formula: | C4 H9 N O3 S | SMILES: | O=C(O)C(N)CSCO | InChi: | InChI=1S/C4H9NO3S/c5-3(4(7)8)1-9-2-6/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | Definition date: | 2007-04-30 | Last modified: | 2024-09-27 | Identifier: | S-(hydroxymethyl)-L-cysteine |
|
 | M2L | Name: | (2R)-2-amino-3-(2-dimethylaminoethylsulfanyl)propanoic acid | Formula: | C7 H16 N2 O2 S | SMILES: | O=C(O)C(N)CSCCN(C)C | InChi: | InChI=1S/C7H16N2O2S/c1-9(2)3-4-12-5-6(8)7(10)11/h6H,3-5,8H2,1-2H3,(H,10,11)/t6-/m0/s1 | Definition date: | 2008-04-09 | Last modified: | 2024-09-27 | Identifier: | S-[2-(dimethylamino)ethyl]-L-cysteine |
|
 | 4QK | Name: | 6-[4-(2-aminoethyl)-1H-1,2,3-triazol-1-yl]-L-norleucine | Formula: | C10 H19 N5 O2 | SMILES: | NC(CCCCn1cc(CCN)nn1)C(O)=O | InChi: | InChI=1S/C10H19N5O2/c11-5-4-8-7-15(14-13-8)6-2-1-3-9(12)10(16)17/h7,9H,1-6,11-12H2,(H,16,17)/t9-/m0/s1 | Definition date: | 2016-07-19 | Last modified: | 2024-09-27 | Release date: | 2016-09-21 | Identifier: | 6-[4-(2-aminoethyl)-1H-1,2,3-triazol-1-yl]-L-norleucine |
|
 | 2CO | Name: | S-HYDROPEROXYCYSTEINE | Formula: | C3 H7 N O4 S | SMILES: | O=C(O)C(N)CSOO | InChi: | InChI=1S/C3H7NO4S/c4-2(3(5)6)1-9-8-7/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 | Definition date: | 2007-01-16 | Last modified: | 2024-09-27 | Identifier: | S-hydroperoxy-L-cysteine |
|
 | TS5 | Name: | GLUTATHIONYLSPERMIDINE | Formula: | C17 H34 N6 O5 S | SMILES: | O=C(NCC(=O)NCCCNCCCCN)C(NC(=O)CCC(C(=O)O)N)CS | InChi: | InChI=1S/C17H34N6O5S/c18-6-1-2-7-20-8-3-9-21-15(25)10-22-16(26)13(11-29)23-14(24)5-4-12(19)17(27)28/h12-13,20,29H,1-11,18-19H2,(H,21,25)(H,22,26)(H,23,24)(H,27,28)/t12-,13-/m0/s1 | Definition date: | 2001-02-28 | Last modified: | 2024-09-27 | Identifier: | L-gamma-glutamyl-L-cysteinyl-N-{3-[(4-aminobutyl)amino]propyl}glycinamide |
|
 | TYX | Name: | S-(2-ANILINO-2-OXOETHYL)-L-CYSTEINE | Formula: | C11 H14 N2 O3 S | SMILES: | O=C(Nc1ccccc1)CSCC(C(=O)O)N | InChi: | InChI=1S/C11H14N2O3S/c12-9(11(15)16)6-17-7-10(14)13-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,14)(H,15,16)/t9-/m0/s1 | Definition date: | 2007-05-07 | Last modified: | 2024-09-27 | Identifier: | S-[2-oxo-2-(phenylamino)ethyl]-L-cysteine |
|
 | BCS | Name: | BENZYLCYSTEINE | Formula: | C10 H13 N O2 S | SMILES: | O=C(O)C(N)CSCc1ccccc1 | InChi: | InChI=1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | S-benzyl-L-cysteine |
|
 | VSZ | Name: | Cystargolide A (bound) | Formula: | C18 H32 N2 O6 | SMILES: | CC[CH](C)[CH](NC(=O)[CH](NC(=O)[CH](O)[CH](C=O)C(C)C)C(C)C)C(O)=O | InChi: | InChI=1S/C18H32N2O6/c1-7-11(6)14(18(25)26)20-16(23)13(10(4)5)19-17(24)15(22)12(8-21)9(2)3/h8-15,22H,7H2,1-6H3,(H,19,24)(H,20,23)(H,25,26)/t11-,12-,13-,14-,15+/m0/s1 | Synonyms: | (2S,3S)-2-[[(2S)-2-[[(2R,3S)-3-methanoyl-4-methyl-2-oxidanyl-pentanoyl]amino]-3-methyl-butanoyl]amino]-3-methyl-pentanoic acid | Definition date: | 2023-03-31 | Last modified: | 2024-09-27 | Release date: | 2023-12-06 | Identifier: | (2~{S},3~{S})-2-[[(2~{S})-2-[[(2~{R},3~{S})-3-methanoyl-4-methyl-2-oxidanyl-pentanoyl]amino]-3-methyl-butanoyl]amino]-3-methyl-pentanoic acid |
|